PIK3CA and non-small cell lung carcinoma: <b>Methods</b>: We conducted a retrospective multicenter analysis of 62 patients with histologically confirmed early-stage or advanced NSCLC-harboring <i>PIK3CA</i> alterations (mutations and/or gene amplifications) treated between 2015 and 2022 at three Italian institutions.